Literature DB >> 17267631

Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card.

D Jane Hata1, Leslie Hall, Annette W Fothergill, Davise H Larone, Nancy L Wengenack.   

Abstract

The performance of the new VITEK 2 Advanced Colorimetry yeast identification (YST) card for use with the VITEK 2 system (bioMérieux, Inc., Hazelwood, MO) was compared to that of the API 20C AUX (API) system (bioMérieux SA, Marcy-l'Etoile, France) in a multicenter evaluation. A total of 12 quality control, 64 challenge, and 623 clinical yeast isolates were used in the study. Comparisons of species identification, platform reliability, and substrate reproducibility were made between YST and API, with API considered the reference standard. Quality control testing to assess system and substrate reproducibility matched expected results >/=95% of the time. The YST card correctly identified 100% of the challenge strains, which covered the species range of the manufacturer's performance claims. Using clinical isolates, the YST card correctly identified 98.5%, with 1.0% of isolates incorrectly identified and 0.5% unidentified. Among clinical isolates, the YST card generated fewer low-discrimination results (18.9%) than did API (30.0%). The time to identification with YST was 18 h, compared to 48 to 72 h with API. The colorimetric YST card used with the VITEK 2 provides a highly automated, objective yeast identification method with excellent performance and reproducibility. We found this system useful for timely and accurate identification of significant yeast species in the clinical microbiology laboratory.

Entities:  

Mesh:

Year:  2007        PMID: 17267631      PMCID: PMC1865816          DOI: 10.1128/JCM.01754-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 2.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

3.  Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species.

Authors:  J S Heelan; E Sotomayor; K Coon; J B D'Arezzo
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens.

Authors:  A Espinel-Ingroff; L Stockman; G Roberts; D Pincus; J Pollack; J Marler
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

5.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory.

Authors:  J K Wadlin; G Hanko; R Stewart; J Pape; I Nachamkin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Comparative study of seven commercial yeast identification systems.

Authors:  P E Verweij; I M Breuker; A J Rijs; J F Meis
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

8.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

9.  New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis.

Authors:  B Sendid; M Tabouret; J L Poirot; D Mathieu; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

View more
  17 in total

1.  Visual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes.

Authors:  Michela De Luca Ferrari; Mariângela Ribeiro Resende; Kanae Sakai; Yasunori Muraosa; Luzia Lyra; Tohru Gonoi; Yuzuru Mikami; Kenichiro Tominaga; Katsuhiko Kamei; Angelica Zaninelli Schreiber; Plinio Trabasso; Maria Luiza Moretti
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

2.  Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.

Authors:  Lars F Westblade; Rebecca Jennemann; John A Branda; Maureen Bythrow; Mary Jane Ferraro; Omai B Garner; Christine C Ginocchio; Michael A Lewinski; Ryhana Manji; A Brian Mochon; Gary W Procop; Sandra S Richter; Jenna A Rychert; Linda Sercia; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Authors:  Joseph Meletiadis; Michael Arabatzis; Maria Bompola; Konstantinos Tsiveriotis; Stavroula Hini; Efthymia Petinaki; Aristea Velegraki; Loukia Zerva
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

4.  Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast.

Authors:  Neelam Dhiman; Leslie Hall; Sherri L Wohlfiel; Seanne P Buckwalter; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

5.  Biographical Feature: Davise H. Larone, Ph.D.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 6.  Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.

Authors:  Brunella Posteraro; Ljupcho Efremov; Emanuele Leoncini; Rosarita Amore; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

7.  Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.

Authors:  M A Pence; E McElvania TeKippe; M A Wallace; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

8.  Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods.

Authors:  Muriel Cornet; Boualem Sendid; Chantal Fradin; Claude Gaillardin; Daniel Poulain; Huu-Vang Nguyen
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

9.  Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures.

Authors:  Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal:  Mycopathologia       Date:  2012-01-11       Impact factor: 2.574

10.  Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.

Authors:  Mariana Castanheira; Leah N Woosley; Daniel J Diekema; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.